Veterans Affairs Center for Clinical Management Research, LTC Charles S. Kettles Veterans Affairs Medical Center, Ann Arbor, Michigan, USA.
Division of Gastroenterology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Am J Gastroenterol. 2023 Jul 1;118(7):1168-1174. doi: 10.14309/ajg.0000000000002204. Epub 2023 Jan 30.
Guidelines suggest 1-time screening with esophagogastroduodenoscopy (EGD) for Barrett's esophagus (BE) in individuals at an increased risk of esophageal adenocarcinoma (EAC). We aimed to estimate the yield of repeat EGD performed at prolonged intervals after a normal index EGD.
We conducted a national retrospective analysis within the U S Veterans Health Administration, identifying patients with a normal index EGD between 2003 and 2009 who subsequently had a repeat EGD. We tabulated the proportion with a new diagnosis of BE, EAC, or esophagogastric junction adenocarcinoma (EGJAC) and conducted manual chart review of a sample. We fitted logistic regression models for the odds of a new diagnosis of BE/EAC/EGJAC.
We identified 71,216 individuals who had a repeat EGD between 1 and 16 years after an index EGD without billing or cancer registry codes for BE/EAC/EGJAC. Of them, 4,088 had a new billing or cancer registry code for BE/EAC/EGJAC after the repeat EGD. On manual review of a stratified sample, most did not truly have new BE/EAC/EGJAC. A longer duration between EGD was associated with greater odds of a new diagnosis (adjusted odds ratio [aOR] for each 5 years 1.31; 95% confidence interval [CI] 1.19-1.44), particularly among those who were younger during the index EGD (ages 19-29 years: aOR 3.92; 95% CI 1.24-12.4; ages 60-69 years: aOR 1.19; 95% CI 1.01-1.40).
The yield of repeat EGD for BE/EAC/EGJAC seems to increase with time after a normal index EGD, particularly for younger individuals. Prospective studies are warranted to confirm these findings.
指南建议对有食管腺癌(EAC)风险增加的个体进行一次性食管胃十二指肠镜检查(EGD)筛查 Barrett 食管(BE)。我们旨在评估在正常指数 EGD 后延长间隔进行重复 EGD 的效果。
我们在美国退伍军人健康管理局内进行了全国性回顾性分析,确定了 2003 年至 2009 年间接受正常指数 EGD 检查后随后进行重复 EGD 的患者。我们列出了新诊断为 BE、EAC 或食管胃交界处腺癌(EGJAC)的比例,并对样本进行了手动图表审查。我们拟合了逻辑回归模型,以评估新诊断为 BE/EAC/EGJAC 的可能性。
我们确定了 71216 名在指数 EGD 后 1 至 16 年内进行重复 EGD 的患者,这些患者没有 EGD 后 1 至 16 年内 BE/EAC/EGJAC 的计费或癌症登记代码。其中,4088 人在重复 EGD 后有新的 BE/EAC/EGJAC 计费或癌症登记代码。在分层样本的手动审查中,大多数患者并未真正患有新的 BE/EAC/EGJAC。重复 EGD 之间的时间间隔越长,新诊断的可能性就越大(每 5 年调整后的比值比[aOR]为 1.31;95%置信区间[CI]为 1.19-1.44),尤其是在指数 EGD 期间年龄较小的患者中(年龄 19-29 岁:aOR 3.92;95% CI 1.24-12.4;年龄 60-69 岁:aOR 1.19;95% CI 1.01-1.40)。
正常指数 EGD 后重复 EGD 对 BE/EAC/EGJAC 的检出率似乎随时间而增加,尤其是在年轻患者中。需要进行前瞻性研究来证实这些发现。